(Q38856274)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Michael J Ausserlechner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

U Kiechl-Kohlendorfer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

P Obexer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

English

0 references

publication date

6 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2052-2061

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2015.264

18 February 2020

exact match

0 references

cites work

Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Analysis of human transcriptomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Necroptosis in health and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Does autophagy contribute to cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Autophagy as a pro-death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Autophagy in health and disease: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

The Beclin 1 network regulates autophagy and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Tumor glycolysis as a target for cancer therapy: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Proliferation enhanced by NGF-NTRK1 signaling makes pancreatic cancer cells more sensitive to 2DG-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

2-deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Glucose-starved cells do not engage in prosurvival autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Autophagy in the cellular energetic balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Mitophagy: a complex mechanism of mitochondrial removal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Targeting survivin in cancer: novel drug development approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Survivin, versatile modulation of cell division and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Differential requirements for survivin in hematopoietic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Regulation of survivin function by Hsp90

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Rational design of shepherdin, a novel anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

FOXO3/FKHRL1 is activated by 5-aza-2-deoxycytidine and induces silenced caspase-8 in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Selective escape of proteins from the mitochondria during mitophagy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.264

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26148234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26148234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2015.264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26148234%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

18 February 2020

0 references

1 reference